Warning Issued on Potentially Deadly Mosquito-Borne Virus in Michigan
Suspected case of EEE in a resident of Barry County was announced earlier this week by state officials
Viral Infections
MPR Weekly Dose Podcast Episode 51
This week we cover AstraZeneca and the swift decision to restart their COVID-19 vaccine candidate trial; Pfizer and BioNTech want to expand enrollment for their candidate vaccine trial; There’s the Janus kinase inhibitor that could help reduce recovery time; An investigative antiviral may ease strain on hospitalizations; Aortic aneurysm, dissection assessed with fluoroquinolones; And a retrospective study compared cardiac events with azithromycin and amoxicillin use.
Early Data Suggest Antibody Therapy May Cut COVID-19 Hospitalizations
The ongoing randomized, double-blind, placebo-controlled BLAZE-1 trial is investigating the treatment in adult patients with mild to moderate COVID-19 symptoms who are not currently hospitalized.
Characteristics ID’d for Under 21s With SARS-CoV-2-Linked Deaths
Teens and young adults, those with underlying medical conditions over-represented among decedents.
Baricitinib Plus Remdesivir Cuts Time to Recovery for Hospitalized COVID-19 Patients
The ACTT-2 study began on May 8 and included more than 1000 patients.
Effectiveness of Inhaled COVID-19 Vaccines to Be Studied
Trial will test responses of 30 adults when they inhale vaccine droplets in their mouths.
Florida Teen Dies From Brain-Eating Amoeba
Naegleria fowleri can get into the brain when contaminated water enters the nose.
MPR Weekly Dose Podcast Episode 50
We cover AstraZeneca’s decision to pause their COVID-19 vaccine trial; New studies indicate benefits for steroid therapy in COVID patients; Higher doses of diabetes treatment gain approval; The first non-hormonal contraceptive is launched; The FDA issues a letter regarding spinal cord stimulators; And we wrap up the latest news on drugs in the pipeline.
Increase Seen in Hydroxychloroquine Rx by Nonroutine Specialists
New Rx increased 80-fold among specialists who do not typically prescribe these medications.
AstraZeneca Pauses COVID-19 Vaccine Trials
In a statement, the Company noted that the actions being taken are considered “routine” when an unexplained illness is reported in a clinical trial.
